Esserose 450 minskintercaps improves symptoms of liver pathology (5 blisters x 10 tablets)

Dosage form Soft capsules
Specifications Box of 5 blisters x 10 tablets
Ingredient Soy phospholipid

Ingredient

Composition information	Content
Soy phospholipid	450mg

Uses

indications

Esserose 450 drugs are indicated in the following cases:

Improve symptoms of liver pathology such as anorexia, lower right flank pain, liver damage due to toxicity and hepatitis.

Pharmacokology

Among the pharmacological properties reported, the liver protection effect is found in many experimental models of acute liver damage, such as Ethanol liver damage, alkyl alcohol, tetrachloride, paracetamol and galactosamine. In addition, for chronic lesions (due to ethanol, thioacetamid, organic solvent), it is also seen inhibitors of fatty liver and fibrosis, because the active ingredient is thought to increase regeneration and stability of cell membranes, inhibition of lipid peroxide and collagen synthesis.

Dynamic pharmacokinetics

animal pharmacokinetic experiments show that more than 90% of soy phospholipid dose have been absorbed in the small intestine. Most of the phospholipase A is separated into 1 - acyl - lysophosphoridylcholin, 50% of this substance is immediately re -acylized to phosphatidylcholine multi -connected double connected into the blood via lymph and thereby mainly attached to HDL to go to the liver.

Human pharmacokinetic tests are performed with Dilinoleyl - Phosphatidylcholin marking radioactive isotope (3H and 14C). The cholin part is marked with 3 hours and linoleic acid is marked with 14C.

The maximum 3H concentration is achieved after 6 to 24 hours and accounts for 19.9% of the dose. The half -life of cholin component is 66 hours.

The concentration of 14C is achieved after 4 to 12 hours and accounts for 27.9% of the dose. The half -life of this component is 32 hours.

In terms of excretion, 2% of 3H and 4.5% 14C markers are found in feces, 6% of 3H markers and only a small amount of 14C are found in urine.

Before taking Esserose 450 minskintercaps improves symptoms of liver pathology (5 blisters x 10 tablets)

How to use

Take oral use.

Take Esserose 450 during meals with lots of water (200 ml), no chewing.

Dosage

Adults: Take 2 times a day, 2 capsules each time. Total dose 1,800 mg/day.

Do not use this drug for children under 18 years of age due to not being fully studied.

Note: The above dose is for reference only. Specific dosage depends on the condition and level of progression of the disease. For a suitable dose, you need to consult a doctor or medical specialist.What to do when overdose?

Symptomatic treatment in case of increasing unwanted effects of the drug on patients using the recommended overdose.

What to do when you forget a dose? However, if close to the next dose, skip the forgotten dose and take the next dose at the time as planned. Note that it should not be used double the prescribed dose.

Side Effects

When using Esserose 450, you may experience unwanted effects (ADR).

Rare (ADR

Gastrointestinal disorders such as gastric disorders, soft stools, diarrhea may occur.

Very rare (ADR

Allergic reactions such as: skin rash.

Unknown frequency

itching.

Instructions on how to handle ADR

When experiencing side effects of the drug, it is necessary to stop using and notify the doctor or go to the nearest medical facility for timely treatment.

Warnings

Before using the drug you need to read the instructions carefully and refer to the information below.

Contraindicated

Esserose 450 contraindications in the following cases:

In cases of hypersensitivity to soy protein, peanut or any ingredient of the drug.

Be cautious when using

Cases of malabsorption may increase the risk of diarrhea or fertilizer fat when using Esserose 450.

Children

Non -recommended drugs for children under 18 years old.

Elderly and/or renal failure

No special attention in these patients, the same dose as on adults.

The ability to drive and operate machinery

There is no drug report that affects the ability to drive and operate machinery.

Pregnancy

There is no information on the safety and effectiveness of the drug in pregnant women, so it should not be used for pregnant women.

The period of breastfeeding

There is no information on the safety and effectiveness of the drug in nursing women, so it should not be used for breastfeeding women.

Interactive drug

Esserose 450 can increase the effects of anticoagulants when used simultaneously with these drugs. Therefore, blood clotting time must be monitored when used simultaneously Esserose 450 and anticoagulants.

Storage

Store in a dry place, avoid light, temperature below 30 ° C.

Other drugs

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.